You are here

Illés Árpád

Illés Árpád

Illés Árpád
DE > ÁOK
Division of Haematology
egyetemi tanár
Name: Illés Árpád
Other profiles: MTMT
Profession: physician

Publication list

Uploaded publications:
394
Publications in DEA:
381
OA:
75
Date range:
1982-2022
2022
  1. Ghia, P., Pluta, A., Wach, M., Lysak, D., Simkovic, M., Kriachok, I., Illés, Á., de la Serna, J., Dolan, S., Campbell, P., Musuraca, G., Jacob, A., Avery, E., Lee, J., Usenko, G., Wang, M., Yu, T., Jurczak, W.: Acalabrutinib Versus Investigator's Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results.
    Hemasphere. 6 (12), 1-10, 2022.
    Journal metrics:
    Q1 Hematology (2021)
  2. Jóna, Á., Kenyeres, A., Barna, S., Illés, Á., Simon, Z.: Clinical and biological prognostic factors in follicular lymphoma patients.
    PLoS One. 17 (8), 1-14, 2022.
    Journal metrics:
    Q1 Multidisciplinary (2021)
  3. Husi, K., Pinczés, L., Fejes, Z., Nagy, B., Illés, Á., Miltényi, Z.: Combined prognostic role of TARC and interim 18F-FDG PET/CT in patients with Hodgkin lymphoma-real world observational study.
    Hell. J. Nucl. Med. 25 (2), 125-131, 2022.
    Journal metrics:
    Q4 Medicine (miscellaneous) (2021)
    Q4 Radiology, Nuclear Medicine and Imaging (2021)
  4. Magyari, F., Pinczés, L., Páyer, E., Farkas, K., Ujfalusi, S., Diószegi, Á., Sik, M., Simon, Z., Nagy, G., Hevessy, Z., Nagy, B., Illés, Á.: Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies.
    Ann. Hematol. 101 (10), 2337-2345, 2022.
    Journal metrics:
    Q2 Hematology (2021)
    Q1 Medicine (miscellaneous) (2021)
  5. Fésüs, A., Benkő, R., Matuz, M., Engi, Z., Ruzsa, R., Hambalek, H., Illés, Á., Kardos, G.: Impact of Guideline Adherence on Outcomes in Patients Hospitalized with Community-Acquired Pneumonia (CAP) in Hungary: a Retrospective Observational Study.
    Antibiotics-Basel. 11 (4), 1-17, 2022.
    Journal metrics:
    Q2 Biochemistry (2021)
    Q2 Infectious Diseases (2021)
    Q2 Microbiology (2021)
    Q2 Microbiology (medical) (2021)
    Q2 Pharmacology (medical) (2021)
    Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (2021)
  6. Kiladjian, J., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva-Kyuchukova, L., Egyed, M., Dulicek, P., Illés, Á., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Krejcy, K., Empson, V., Hasselbalch, H., Kralovics, R., Gisslinger, H., PROUD-PV Study Group: Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b.
    Leukemia. 36 (5), 1408-1411, 2022.
    Journal metrics:
    D1 Anesthesiology and Pain Medicine (2021)
    D1 Cancer Research (2021)
    D1 Hematology (2021)
    D1 Oncology (2021)
  7. Pratz, K., Jonas, B., Pullarkat, V., Recher, C., Schuh, A., Thirman, M., Garcia, J., DiNardo, C., Vorobyev, V., Fracchiolla, N., Yeh, S., Jang, J., Ozcan, M., Yamamoto, K., Illés, Á., Zhou, Y., Dail, M., Chyla, B., Potluri, J., Döhner, H.: Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine.
    J. Clin. Oncol. 40 (8), 855-865, 2022.
    Journal metrics:
    D1 Cancer Research (2021)
    D1 Medicine (miscellaneous) (2021)
    D1 Oncology (2021)
  8. Schjesvold, F., Dimopoulos, M., Delimpasi, S., Robak, P., Coriu, D., Legiec, W., Pour, L., Špička, I., Masszi, T., Doronin, V., Minarik, J., Salogub, G., Alekseeva, Y., Lazzaro, A., Maisnar, V., Mikala, G., Rosinol, L., Liberati, A., Symeonidis, A., Moody, V., Thuresson, M., Byrne, C., Harmenberg, J., Bakker, N., Hájek, R., Mateos, M., Richardson, P., Sonneveld, P., OCEAN (OP-103) Investigators: Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.
    The Lancet Haematology. 9 (2), e98-e110, 2022.
  9. Lovas, S., Obajed Al-Ali, N., Varga, G., Szita, V., Alizadeh, H., Plander, M., Rajnics, P., Illés, Á., Szemlaky, Z., Mikala, G., Váróczy, L.: Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients: Real-World Data From Hungary.
    Pathol. Oncol. Res. 28 1-7, 2022.
    Journal metrics:
    Q3 Cancer Research (2021)
    Q2 Medicine (miscellaneous) (2021)
    Q3 Oncology (2021)
    Q2 Pathology and Forensic Medicine (2021)
2021
  1. Byrd, J., Hillmen, P., Ghia, P., Kater, A., Chanan-Khan, A., Furman, R., O'Brien, S., Yenerel, M., Illés, Á., Kay, N., Garcia-Marco, J., Mato, A., Pinilla-Ibarz, J., Seymour, J., Lepretre, S., Stilgenbauer, S., Robak, T., Rothbaum, W., Izumi, R., Hamdy, A., Patel, P., Higgins, K., Sohoni, S., Jurczak, W.: Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: results of the First Randomized Phase III Trial.
    J. Clin. Oncol. 39 (31), 3441-3452, 2021.
    Journal metrics:
    D1 Cancer Research
    D1 Medicine (miscellaneous)
    D1 Oncology
  2. Szász, R., Illés, Á.: A krónikus lymphoid leukaemia mai kezelésének interdiszciplináris kérdései.
    Orv. hetil. 162 (9), 336-343, 2021.
    Journal metrics:
    Q4 Medicine (miscellaneous)
  3. Kellner, Á., Kellner, V., Rajnics, P., Karádi, É., Illés, Á., Udvardy, M., Homor, L., Dombi, P., Herczeg, J., Sipiczki, Z., Győriné, K., Egyed, M.: Analysis of Thrombosis Risk Stratification Models Based on 10 Years Follow Up of 237 Essential Thrombocythemia Patients.
    J. Blood & Lymph. 11 (2), 1-7, 2021.
  4. Illés, Á., Pinczés, L., Egyed, M.: A pharmacokinetic evaluation of ropeginterferon alfa-2b in the treatment of polycythemia vera.
    Expert Opin. Drug Metab. Toxicol. 17 (1), 3-7, 2021.
    Journal metrics:
    Q1 Medicine (miscellaneous)
    Q2 Pharmacology
    Q1 Toxicology
  5. Morschhauser, F., Feugier, P., Flinn, I., Gasiorowski, R., Greil, R., Illés, Á., Johnson, N., Larouche, J., Lugtenburg, P., Patti, C., Salles, G., Tmĕný, M., Vos, S., Mir, F., Samineni, D., Kim, S., Jiang, Y., Punnoose, E., Sinha, A., Clark, E., Spielewoy, N., Humphrey, K., Bazeos, A., Zelenetz, A.: A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
    Blood. 137 (5), 600-609, 2021.
    Journal metrics:
    D1 Biochemistry
    D1 Cell Biology
    D1 Hematology
    D1 Immunology
  6. Varga, G., Tóth, A., Virág, R., Csukly, Z., Hardi, A., Gaál-Weisinger, J., Nagy, Z., Altai, E., Rencsik, A., Plander, M., Szendrei, T., Kórád, K., Radványi, G., Rottek, J., Deák, B., Szaleczky, E., Schneider, T., Kohl, Z., Kosztolányi, S., Alizadeh, H., Lengyel, Z., Modok, S., Borbényi, Z., Lovas, S., Váróczy, L., Illés, Á., Rajnics, P., Masszi, T., Mikala, G.: Beneficial Effect of Lenalidomide-Dexamethason Treatment in Relapsed/Refractory Multiple Myeloma Patients: results of Real-Life Data From 11 Hungarian Centers.
    Pathol. Oncol. Res. 27 1-6, 2021.
    Journal metrics:
    Q3 Cancer Research
    Q2 Medicine (miscellaneous)
    Q3 Oncology
    Q2 Pathology and Forensic Medicine
  7. Hutchings, M., Radford, J., Ansell, S., Illés, Á., Sureda, A., Connors, J., Sýkorová, A., Shibayama, H., Abramson, J., Chua, N., Friedberg, J., Kořen, J., LaCasce, A., Molina, L., Engley, G., Fenton, K., Jolin, H., Liu, R., Gautam, A., Gallamini, A.: Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: a prespecified subgroup analysis of high-risk patients from the ECHELON-1 study.
    Hematol. Oncol. 39 (2), 185-195, 2021.
    Journal metrics:
    Q2 Cancer Research
    Q2 Hematology
    Q1 Medicine (miscellaneous)
    Q2 Oncology
  8. Straus, D., Dugosz-Danecka, M., Connors, J., Alekseev, S., Illés, Á., Picardi, M., Lech-Maranda, E., Feldman, T., Smolewski, P., Savage, K., Bartlett, N., Walewski, J., Ramchandren, R., Zinzani, P., Hutchings, M., Munoz, J., Lee, H., Kim, W., Advani, R., Ansell, S., Younes, A., Gallamini, A., Liu, R., Little, M., Fenton, K., Fanale, M., Radford, J.: Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial.
    The Lancet Haematology. 8 (6), e410-e421, 2021.
    Journal metrics:
    D1 Hematology
  9. Pfliegler, G., Illés, Á.: COVID-19 és haemostasis.
    Hematol. Trasnzfuziol. 54 (4), 184-191, 2021.
Show all
updated: 2023-03-19, 01:32

SCImago quartiles of
scientific journal articles

Number of scientific articles: 282
Q1/D1 21 (7.4%)
Q1 56 (19.9%)
Q2 45 (16%)
Q3 33 (11.7%)
Q4 26 (9.2%)
N/A 122 (43.3%)
-
OK

SCImago subject areas and categories

Medicine (157)
Medicine (miscellaneous) (112)
Oncology (49)
Hematology (45)
Pathology and Forensic Medicine (22)
Immunology and Allergy (10)
Rheumatology (7)
Anesthesiology and Pain Medicine (2)
Pharmacology (medical) (2)
Public Health, Environmental and Occupational Health (2)
Gastroenterology (1)
Geriatrics and Gerontology (1)
Histology (1)
Infectious Diseases (1)
Microbiology (medical) (1)
Neurology (clinical) (1)
Pediatrics, Perinatology and Child Health (1)
Radiology, Nuclear Medicine and Imaging (1)
Surgery (1)
Transplantation (1)
Biochemistry, Genetics and Molecular Biology (47)
Cancer Research (39)
Cell Biology (5)
Biochemistry (4)
Molecular Biology (4)
Genetics (2)
Aging (1)
Biochemistry, Genetics and Molecular Biology (miscellaneous) (1)
Immunology and Microbiology (16)
Immunology (15)
Microbiology (1)
Pharmacology, Toxicology and Pharmaceutics (3)
Pharmacology (2)
Toxicology (2)
Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (1)
Chemical Engineering (2)
Catalysis (2)
Chemistry (2)
Inorganic Chemistry (2)
Organic Chemistry (2)
Physical and Theoretical Chemistry (2)
Spectroscopy (2)
Computer Science (2)
Computer Science Applications (2)
Agricultural and Biological Sciences (1)
Agricultural and Biological Sciences (miscellaneous) (1)
Multidisciplinary (1)
Multidisciplinary (1)
Neuroscience (1)
Neurology (1)
Nursing (1)
Gerontology (1)
Social Sciences (1)
Health (social science) (1)

Genre chart

Year chart

Language chart

Journals

Show more

iDEa co-authors

Show more

Other co-authors

Show more
Bicskó Ráhel Réka
Morschhauser, Franck
Forero-Torres, Andres
Kosztolányi Szabolcs
Ramchandren, Radhakrishnan
Barrientos, Jacqueline C.
Dimopoulos, Meletios A.
DiNardo, Courtney D.
Garcia, Jacqueline S.
Gercheva-Kyuchukova, Liana
Győriné Korom Viktória
Hasselbalch, Hans C.
Kiladjian, Jean-Jacques
Krochmalczyk, Dorota
Pristupa, Alexander S.
Stilgenbauer, Stephan
Andrikovics Hajnalka
Bodnár Gabriella Zsuzsa
Bollard, Catherine M.
Christensen, Jacob Haaber
Cymbalista, Florence
Domingo-Domenech, Eva
Dugosz-Danecka, Monika
Długosz-Danecka, Monika
Fracchiolla, Nicola S.
Friedberg, Jonathan W.
Gaál-Weisinger Júlia
Garcia-Marco, Jose A.
Grohmann-Izay, Barbara
Hungria, Vania T. M.
Johnson, Nathalie A.
LaCasce, Ann Steward
Larouche, Jean-Francois
Liberati, Anna Marina
Lugtenburg, Pieternella J.
Maison-Blanche, Pierre
Mateos, Maria-Victoria
Medeiros, L. Jeffrey
Nagy Gergely György
Pinilla-Ibarz, Javier
Polprasert, Chantana
Rajkumar, S. Vincent
San-Miguel, Jesus F.
Stilgenbaur, Stephan
Yenerel, Mustafa Nuri